Effects of isoniazid (INH) on the BCG-induced local immune response after intravesical BCG therapy for superficial bladder cancer

This publication has 26 references indexed in Scilit:

• Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer
  Cancer Immunology, Immunotherapy, 1992
• Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?
  Urological Research, 1992
• Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin
  Cancer Immunology, Immunotherapy, 1991
• Selection of a human T helper type 1-like T cell subset by mycobacteria.
  The Journal of Experimental Medicine, 1991
• Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer
  Urological Research, 1991
• Detection of urinary TNF, IL 1, and IL 2 after local BCG immunotherapy for bladder carcinoma
  Cytokine, 1990
• Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guérin
  Cancer Immunology, Immunotherapy, 1990
• HLA—DR Expression by High Grade Superficial Bladder Cancer Treated with BCG
  British Journal of Urology, 1989
• Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancer
  Clinical Immunology and Immunopathology, 1986
• Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy
  Cancer Immunology, Immunotherapy, 1986